Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic versus brand triptorelin in metastatic prostate cancer
IRCT2016090410178N10Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triptorelin in prostate cancer (PCa) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Prostate specific antigen serum level and Testosterone serum level. Started Oct 2016; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on IRCT2016090410178N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016090410178N10.